U.S. officials have reported new day-to-day recordings of some of the latest developments in the world of CV-19, announcing the transition to a global effort to accelerate and share new technologies.
Cases of later Omicron outbreaks are rapidly increasing
In the middle of March, the highest daily record in Hong Kong reached 56,827. In a brief statement today, health officials urged the community to stay at home as much as possible. He said support from the mainland has continued, including the arrival of Chinese medicines. The supply of food to Hong Kong is constant, and people should not panic in stores, the group added.
South Korea cases have risen to 240,000 for the first time today, with more than 60% reported in the Seoul area, Yonhap News reported. The government has banned vaccinations due to staff shortages and health officials expect cases to be high in mid-March.
In Japan, among the countries that have reported Omicron differences, hospitals are still under pressure, but issues are declining, Reuters reported. Fifteen provinces are demanding an extension of the Soccer Emergency Proclamation. However, the authorities are expected to ease some restrictions.
Elsewhere, surgery in New Zealand continues, with 23,183 new cases today, and officials expect hospital stays to increase and cases to be higher in the next two weeks, Radio New Zealand reports.
Technology transfer is focused on equitable access.
Officials at the National Institutes of Health (NIH) announced that the National Institutes of Health (NIH) will provide a range of technologies for the Covenant-19 access pool, during a virtual meeting with international health ministers to discuss the lessons learned from today’s epidemic. .
With open licensing agreements, the licensing pool, which opened in 2020, is designed to fight new devices for Covidy-19 and accelerate more equitable distribution.
In a joint statement with the United Nations Pharmaceutical Pool, the groups welcomed NIH’s offer. Dr. Tewodros Adhanom Gebre-Jesus, Director-General of the World Health Organization (WHO), said: Get access to medical products and fair access. “
He said the donations do not include Moderena vaccine technology or those sold by private companies to the US market Washington Post.
In other developments:
- The World Health Organization (WHO) has today revised its guidelines for treatment, including conditional recommendations for patients with mild to moderate SARS-CoV-2 antibodies to SARS-CoV-2. The agency also stated that Monochlonal Antibodies Cocktail Casirivimab-Imdevimab should not be used in patients with oxycodone infection due to its ineffectiveness.
- Researchers at a UK-based recovery trial found that COVID-19 could significantly reduce the risk of dying from baritinsib in a preliminary study today, a level less than in previous experiments. Combined with other studies in meta-analysis, the group predicted a 20% reduction in mortality. The drug is an anti-inflammatory for rheumatoid arthritis, it can be combined with other treatments for additional benefits.
- According to the Johns Hopkins Online Dashboard, 441,662,460 cases and 5,980,210 people have died worldwide.